(1R,2R,3S,3aR,8bS)-6-((2S,3R,6R)-6-((S)-1,2-dihydroxyethyl)-3-methoxy-1,4-dioxan-2-yloxy)-1,8b-dihydroxy-8-methoxy-3a-(4-methoxyphenyl)-N-((1-(15-oxo-19-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-14-azanonadecyl)-1H-1,2,3-triazol-4-yl)methyl)-3-phenyl-2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan-2-carboxamide

ID: ALA3752463

Chembl Id: CHEMBL3752463

PubChem CID: 102191529

Max Phase: Preclinical

Molecular Formula: C56H75N7O17S

Molecular Weight: 1150.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc([C@@]23Oc4cc(O[C@@H]5O[C@@H]([C@@H](O)CO)CO[C@H]5OC)cc(OC)c4[C@]2(O)[C@H](O)[C@H](C(=O)NCc2cn(CCCOCCOCCOCCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@@H]54)nn2)[C@H]3c2ccccc2)cc1

Standard InChI:  InChI=1S/C56H75N7O17S/c1-71-37-17-15-35(16-18-37)56-47(34-11-5-4-6-12-34)46(50(67)55(56,70)48-41(72-2)27-38(28-42(48)80-56)78-53-52(73-3)77-32-43(79-53)40(65)31-64)51(68)58-29-36-30-63(62-61-36)20-10-22-75-24-26-76-25-23-74-21-9-19-57-45(66)14-8-7-13-44-49-39(33-81-44)59-54(69)60-49/h4-6,11-12,15-18,27-28,30,39-40,43-44,46-47,49-50,52-53,64-65,67,70H,7-10,13-14,19-26,29,31-33H2,1-3H3,(H,57,66)(H,58,68)(H2,59,60,69)/t39-,40-,43+,44-,46+,47+,49-,50+,52+,53+,55-,56-/m0/s1

Standard InChI Key:  CAWYKDWKPYVBRU-SMEJHLNESA-N

Associated Targets(non-human)

Eif4a1 Eukaryotic initiation factor 4A-I (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Eif4a2 Eukaryotic initiation factor 4A-II (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Eif4a3 Eukaryotic initiation factor 4A-III (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Eif4e Eukaryotic translation initiation factor 4E (654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Phb1 Prohibitin (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ddx3x ATP-dependent RNA helicase DDX3X (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1150.32Molecular Weight (Monoisotopic): 1149.4940AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Chambers JM, Lindqvist LM, Savage GP, Rizzacasa MA..  (2016)  Total synthesis of a biotinylated rocaglate: Selective targeting of the translation factors eIF4AI/II.,  26  (2): [PMID:26718843] [10.1016/j.bmcl.2015.12.045]

Source